Publication | Closed Access

Clinical impact of pembrolizumab combined with chemotherapy in elderly patients with advanced non-small-cell lung cancer

Elderly PatientsMedicinePathologyImmune Checkpoint InhibitorBronchial NeoplasmCancer TreatmentLung CancerOncologyRadiation OncologyTumor MicroenvironmentClinical Impact